EGFR and neoplasm: The sizes and weights of the tumours in the Anti-EGFR-CIL-miR-135a group were obviously reduced in comparison to the control (p < 0.001), miR-135a (p < 0.001) or LCL-miR-135a groups (p < 0.01) (Fig. 9A–C).